Radial scleral ablation trial promising for presbyopia

San Diego-Scleral ablation with the 2.94 erbium:YAG laser for the treatment of presbyopia seems to be an effective and safe procedure in most patients, according to Bobby Maddox, MD, here at the American Society of Cataract and Refractive Surgery annual meeting.

Related Videos
New optics textbook aims to be a compendium resource for the topic
Higher rates of repeat corneal crosslinking need found in younger patients
Dispersive ophthalmic viscosurgical device found to be safe, effective in clinical trials
Related Content

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

What patients need to know about cataract surgery

July 5th 2021

The challenges of tube shunts in pediatric glaucoma surgery

March 20th 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

Sight Sciences launching new series of surgical system

March 9th 2023

Botulinum toxin injections offer an alternative to extraocular muscle surgery for comitant esotropia

March 5th 2023

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

What patients need to know about cataract surgery

July 5th 2021

The challenges of tube shunts in pediatric glaucoma surgery

March 20th 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

Sight Sciences launching new series of surgical system

March 9th 2023

Botulinum toxin injections offer an alternative to extraocular muscle surgery for comitant esotropia

March 5th 2023

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

What patients need to know about cataract surgery

July 5th 2021

The challenges of tube shunts in pediatric glaucoma surgery

March 20th 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

Sight Sciences launching new series of surgical system

March 9th 2023

Botulinum toxin injections offer an alternative to extraocular muscle surgery for comitant esotropia

March 5th 2023
© 2023 MJH Life Sciences

All rights reserved.